Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies

Amyloid Beta and Tau as Alzheimer's Disease Blood Biomarkers: Promise From New Technologies - Lue et al. 2017

Amyloid Beta and Tau as Alzheimer's Disease Blood Biomarkers: Promise From New Technologies

© 2017 Lue, Guerra, and Walker

Neurology and Therapy | Volume 6, Pages S26-S36

Previous
Previous

Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer’s Disease

Next
Next

Plasma α-synuclein predicts cognitive decline in Parkinson's disease